Skip to content

BSMed: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BSMed

BE 0788.772.425
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€5,314
2024 · -€9,544+€4,230
Equity
-€4,290
2024 · €1,024-€5,314
Cash
€33
2024 · €537-€504
Balance sheet total
€260,022
2024 · €254,836+€5,186

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€5,690

    up €5,690 (+2.2%), from €254,299 to €259,989

Equity and liabilities
  • Other debts +€10,500

    up €10,500 (+4.1%), from €253,812 to €264,312

  • Profit (loss) carried forward -€5,314

    down €5,314 (-14.0%), from -€37,976 to -€43,290

Income statement
  • Depreciation -€4,773

    down €4,773 (-65.8%), from €7,252 to €2,479

  • Other operating charges +€415

    up €415 (+104.9%), from €396 to €811

  • Gross operating margin -€77

    down €77 (-4.2%), from -€1,847 to -€1,924

  • Financial charges +€51

    up €51 (+104.8%), from €49 to €99

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€9,544
Gross operating margin -€77
Depreciation +€4,773
Other operating charges -€415
Financial charges -€51
Result 2025 -€5,314

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€7,665
Investment -€8,169
Financing €0
Cash 2024 €537
Net result for the year -€5,314
Depreciation +€2,479
Other debts +€10,500
Investment in fixed assets (net) -€8,169
Cash 2025 €33
Every line side by side 22 lines
Line Code 2024 2025 Change %
Total assets 20/58 €254,836 €260,022 +€5,186 +2.0%
Fixed assets 21/28 €254,299 €259,989 +€5,690 +2.2%
Tangible fixed assets 22/27 €254,299 €259,989 +€5,690 +2.2%
Land and buildings 22 €254,299 €259,989 +€5,690 +2.2%
Current assets 29/58 €537 €33 -€504 -93.8%
Cash at bank and in hand 54/58 €537 €33 -€504 -93.8%
Total equity and liabilities 10/49 €254,836 €260,022 +€5,186 +2.0%
Equity 10/15 €1,024 -€4,290 -€5,314
Contributions 10/11 €39,000 €39,000 = 0.0%
Profit (loss) carried forward 14 -€37,976 -€43,290 -€5,314 -14.0%
Amounts payable 17/49 €253,812 €264,312 +€10,500 +4.1%
Amounts payable within one year 42/48 €253,812 €264,312 +€10,500 +4.1%
Other amounts payable 47/48 €253,812 €264,312 +€10,500 +4.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,252 €2,479 -€4,773 -65.8%
Other operating charges 640/8 €396 €811 +€415 +104.9%
Gross operating margin 9900 -€1,847 -€1,924 -€77 -4.2%
Operating profit (loss) 9901 -€9,495 -€5,215 +€4,281 +45.1%
Financial charges 65/66B €49 €99 +€51 +104.8%
Recurring financial charges 65 €49 €99 +€51 +104.8%
Profit (loss) for the period before taxes 9903 -€9,544 -€5,314 +€4,230 +44.3%
Profit (loss) for the period 9904 -€9,544 -€5,314 +€4,230 +44.3%
Profit (loss) for the period to be appropriated 9905 -€9,544 -€5,314 +€4,230 +44.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.